REVERE Breathe

Completed

Conditions: Specialty: Critical care, Primary sub-specialty: Critical Care
UKCRC code/ Disease: Cancer/ Malignant neoplasms of digestive organs
Respiratory
Lung infections after surgery

Registration Number: ISRCTN14521547

Lead Sponsor: niversity of Birmingham

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 25

Inclusion Criteria

Patient
1. All consecutive patients undergoing elective oesophagectomy and total gastrectomy for cancer treatment on their first post-operative admission to the critical care units (intensive care or high dependency units) at QEHB or BHH
2. Age 18 years and over
3. All genders

Staff Inclusion criteria
All clinical, nursing and physiotherapy staff who have had direct care responsibilities for patients participating in the trial will be invited to participate in the focus groups during the study. Physiotherapists, nursing staff and doctors allocated to care for participants will be identified during the intervention days of the study and approached by the research team.

Exclusion Criteria

1. Patient refusal
2. Cognitive impairment preventing patient cooperation with breathing exercises
3. Severe visual impairment, such that the patient is unable to visualise the computer display
4. Post-operative complications necessitating placement of tracheostomy

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Successful patient usage of the InspireVR. Usage will be defined as the total number of successful attempts (patient able to record a MIC breath) using InspireVR compared with number of successful attempts when using Spiroball (as reported by the patient). Feasibility of the device will be established if the number of successful attempts at incentive spirometry during InspireVR use is equal to or higher than the number of patient-reported successful uses of the Spiroball device. InpsireVR usage will be collected via the device software. Use of Spiroball will be reported by the patient and bedside staff using a paper log.

Secondary Outcome Measures